News Daily News El Patrón Re-estenótico tras Colocación de Stent Femoropoplíteo Predice la Recurrencia March 06, 2012
News Daily News El mayor riesgo de episodios cerebrovasculares se da en las primeras 24 horas posteriores a un RVAT March 06, 2012
News Daily News Análisis PLATO: Los IBP son Problemáticos tanto con el Ticagrelor como con el Clopidogrel Caitlin E. Cox March 06, 2012
Presentation Impacto de la Anemia en la Respuesta Plaquetaria al Clopidogrel en Pacientes sometidos a PCI Presenter: C. Toma February 14, 2012
Presentation Impact of Anemia on Platelet Response to Clopidogrel in Patients Undergoing PCI Presenter: Catalin Toma February 14, 2012
Presentation ¿Existe una Interacción Clínica Significativa Entre los Bloqueadores de los Antagonistas de los Canales del Calcio y Clopidogrel? Presenter: Christopher W. Good February 12, 2012
News Daily News No Clinical Interaction Between Calcium Channel Blockers, Clopidogrel Jason Kahn February 12, 2012
Presentation Is There a Clinically Significant Interaction Between Calcium Channel Antagonists and Clopidogrel? Presenter: Christopher W. Good February 12, 2012
News Daily News Similar Mortality Rates Seen in Men and Women with NSTE ACS L.A. McKeown January 26, 2012
News Daily News PROFI Published: Better Cerebral Protection with Balloon Occlusion after CAS Yael L. Maxwell January 25, 2012
Presentation Association of PPI Use and Cardiovascular Outcomes with Clopidogrel and Ticagrelor Presenter: Shaun G. Goodman January 24, 2012
Presentation Relaciones entre el uso de IBP y Desenlaces Cardiovasculares con Clopidogrel y Ticagrelor Presenter: Shaun G. Goodman January 24, 2012
News Daily News Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition L.A. McKeown January 12, 2012
Presentation CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events Presenter: Michael V. Holmes January 04, 2012
Presentation TCT 2012 The impact of paraoxonase-1 activity on the incidence of intra-stent thrombus after drug-eluting stent implantation in the Japanese CYP2C19*2 carriers receiving clopidogrel Presenter: Ryo Nishio, Junya Shite, Toshiro Shinke, Hiromasa Otake, Masayuki Nakagawa, Ryoji Nagoshi, Amane Kozuki, Takumi Inoue, Hirotoshi Hariki, Tsuyoshi Osue, Yu Taniguchi, Masamichi Iwasaki, Noritoshi Hiranuma, Akihide Konishi, Hiroto Kinutani, Yoko Haraguchi, Tatsuro Ishida, Ken-ichi Hirata January 03, 2012
Presentation TCT 2012 The Association Between Duration of Clopidogrel Therapy After Saphenous Vein Graft Intervention And Long-Term Death And Myocardial Infarction Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Vicken Aharonian, Prakash Mansukhani, Gregg W. Stone, Naing Moore, Ric Hyett, Richard Contreras, Somjot S. Brar January 03, 2012
Presentation TCT 2012 Stopping Clopidogrel 1 year After Drug-Eluting Stent (DES) Implantation: Is It Safe? Presenter: Nalyaka Sambu, Hazel Dent, Timothy Warner, Nicola Englyst, Philip Leadbeater, Alex Hobson, Alison Calver, Simon Corbett, Huon Gray, Iain Simpson, John Morgan, Nick Curzen January 03, 2012
Presentation TCT 2012 Protease Activated Receptor-1 (PAR-1) Mediated Platelet Aggregation is Dependant on Clopidogrel Response Presenter: Rolf P. Kreutz, David A. Flockhart, Yvonne Kreutz, Jeffrey A. Breall January 03, 2012